Ignite Creation Date:
2025-12-25 @ 12:11 AM
Ignite Modification Date:
2025-12-25 @ 10:11 PM
Study NCT ID:
NCT00700258
Status:
COMPLETED
Last Update Posted:
2024-09-23
First Post:
2008-06-13
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
Registry For Temsirolimus, Sunitinib, And Axitinib Treated Patients With Metastatic Renal Cell Carcinoma (mRCC), Mantle Cell Lymphoma (MCL), And Gastro-Intestinal Stroma Tumor (GIST) [STAR-TOR]
Sponsor:
Pfizer
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2008-02-13
Start Date Type:
ACTUAL
Primary Completion Date:
2021-12-28
Primary Completion Date Type:
ACTUAL
Completion Date:
2021-12-28
Completion Date Type:
ACTUAL
First Submit Date:
2008-06-13
First Submit QC Date:
None
Study First Post Date:
2008-06-18
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2022-12-07
Results First Submit QC Date:
None
Results First Post Date:
2024-09-23
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-05-21
Last Update Post Date:
2024-09-23
Last Update Post Date Type:
ACTUAL